Position history for Woodline Partners LP's holdings in REGENERON PHARMACEUTICALS
Woodline Partners LP holds 67,751 shares of REGN (REGENERON PHARMACEUTICALS), worth $52.3M as of 2026-Q1. The position was increased (+4.3% shares). REGN represents 0.2% of Woodline Partners LP's portfolio.
Current Value
$52.3M
Current Shares
67,751
Total Value Change
-$138.8M
Total Shares Change
-114,146
Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.
Increased |
| 67,751 |
+4.3% |
| $52.3M |
| 0.2% |
| $766.66 |
37 |
| 2025-Q4 | Increased | 64,968 | +6.6% | $50.1M | 0.2% | $773.94 | 37 |
| 2025-Q3 | Increased | 60,964 | +3.7% | $34.3M | 0.2% | $560.05 | 36 |
| 2025-Q2 | Decreased | 58,778 | -44.7% | $30.9M | 0.2% | $519.56 | 0 |
| 2025-Q1 | Increased | 106,217 | +2.8% | $67.4M | 0.4% | $634.66 | 36 |
| 2024-Q4 | Increased | 103,279 | +3.9% | $73.6M | 0.5% | $698.71 | 37 |
| 2024-Q3 | Decreased | 99,417 | -45.3% | $104.5M | 0.9% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 181,897 | +6.6% | $191.2M | 1.8% | $1,045.23 | 51 |